Cited by 277Drug-Induced Hepatotoxicity and ProtectionMitochondrial Function and PathologyLiver physiology and pathology

The DOI matches its Crossref record; 604 of the 604 references it cites were found in a registry or an index.

Central role of mitochondria in drug-induced liver injury

Pessayre, Dominique, Fromenty, Bernard, Berson, Alain, Robin, Marie-Anne, Lettéron, Philippe, Moreau, Richard, Mansouri, Abdellah·2012·Drug Metabolism Reviews

DOI 10.3109/03602532.2011.604086

Open this paper in CoChat — free account

Abstract

A frequent mechanism for drug-induced liver injury (DILI) is the formation of reactive metabolites that trigger hepatitis through direct toxicity or immune reactions. Both events cause mitochondrial membrane disruption. Genetic or acquired factors predispose to metabolite-mediated hepatitis by increasing the formation of the reactive metabolite, decreasing its detoxification, or by the presence of critical human leukocyte antigen molecule(s). In other instances, the parent drug itself triggers mitochondrial membrane disruption or inhibits mitochondrial function through different mechanisms. Drugs can sequester coenzyme A or can inhibit mitochondrial β-oxidation enzymes, the transfer of electrons along the respiratory chain, or adenosine triphosphate (ATP) synthase. Drugs can also destroy mitochondrial DNA, inhibit its replication, decrease mitochondrial transcripts, or hamper mitochondrial protein synthesis. Quite often, a single drug has many different effects on mitochondrial function. A severe impairment of oxidative phosphorylation decreases hepatic ATP, leading to cell dysfunction or necrosis; it can also secondarily inhibit ß-oxidation, thus causing steatosis, and can also inhibit pyruvate catabolism, leading to lactic acidosis. A severe impairment of β-oxidation can cause a fatty liver; further, decreased gluconeogenesis and increased utilization of glucose to compensate for the inability to oxidize fatty acids, together with the mitochondrial toxicity of accumulated free fatty acids and lipid peroxidation products, may impair energy production, possibly leading to coma and death. Susceptibility to parent drug-mediated mitochondrial dysfunction can be increased by factors impairing the removal of the toxic parent compound or by the presence of other medical condition(s) impairing mitochondrial function. New drug molecules should be screened for possible mitochondrial effects.

Integrity signals

Registry

Crossref · 10.3109/03602532.2011.604086

Cites

604 of 604 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Items 201–400 of 604

Acute Fatty Liver of Pregnancy
Kaplan, M. M. (1985) · New England Journal of Medicine · doi:10.1056/nejm198508083130606 · Cited by 163
Inhibition of Mitochondrial Function by Efavirenz Increases Lipid Content in Hepatic Cells
Blas‐García, A., Apostolova, N., Ballesteros, D., Monleón, D., Morales, J. M., Rocha, M., Víctor, V. M., & Esplugues, J. V. (2010) · Hepatology · doi:10.1002/hep.23647 · Cited by 162
Isoniazid hepatoxicity: the relationship between covalent binding and metabolism in vivo.
Timbrell, J. A., Mitchell, J. R., Snodgrass, W. R., & Nelson, S. D. (1980) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32069-0 · Cited by 161
Impaired oxidation of debrisoquine in patients with perhexiline liver injury.
Morgan, M. Y., Reshef, R., Shah, R. R., Oates, N. S., Smith, R. L., & Sherlock, S. (1984) · Gut · doi:10.1136/gut.25.10.1057 · Cited by 161
Evidence for mitochondrial DNA damage by lipid peroxidation
Hruszkewycz, A. M. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81207-5 · Cited by 158
Human CYP2C9 and CYP2A6 Mediate Formation of the Hepatotoxin 4-Ene-Valproic Acid
Sadeque, A. J. M., Fisher, M. B., Korzekwa, K. R., Gonzalez, F. J., & Rettie, A. E. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37076-4 · Cited by 157
Fas-associated death domain (FADD) is a negative regulator of T-cell receptor–mediated necroptosis
Osborn, S. L., Diehl, G. E., Han, S., Xue, L., Kurd, N. S., Hsieh, K., Cado, D., Robey, E. A., & Winoto, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005997107 · Cited by 156
Use of Pharmaco-Metabonomics for Early Prediction of Acetaminophen-Induced Hepatotoxicity in Humans
Winnike, J., Li, Z., Wright, F. A., Macdonald, J. M., O’Connell, T. M., & Watkins, P. B. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.240 · Cited by 156
Modest Inflammation Enhances Diclofenac Hepatotoxicity in Rats: Role of Neutrophils and Bacterial Translocation
Deng, X., Stachlewitz, R. F., Liguori, M. J., Blomme, E. A. G., Waring, J. F., Luyendyk, J. P., Maddox, J. F., Ganey, P. E., & Roth, R. A. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110247 · Cited by 156
Serum Transaminase Elevations and Other Hepatic Abnormalities in Patients Receiving Isoniazid
Scharer, L. L. M. D., & SMITH, J. P. (1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-71-6-1113 · Cited by 155
BIOACTIVATION OF THE NONTRICYCLIC ANTIDEPRESSANT NEFAZODONE TO A REACTIVE QUINONE-IMINE SPECIES IN HUMAN LIVER MICROSOMES AND RECOMBINANT CYTOCHROME P450 3A4
Kalgutkar, A. S. S., Vaz, A. D. N., Lame, M. E., Henne, K. R., Soglia, J. R., Zhao, S. X., Abramov, Y. A., Lombardo, F., Collin, C., Hendsch, Z. S., et al. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.001735 · Cited by 155
Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscle
Sirvent, P., Mercier, J., Vassort, G., & Lacampagne, A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.070 · Cited by 154
Cytochrome P450 3A4-Mediated Bioactivation of Raloxifene: Irreversible Enzyme Inhibition and Thiol Adduct Formation
Chen, Q., Ngui, J. S., Doss, G. A., Wang, R. W., Cai, X., DiNinno, F. P., Blizzard, T. A., Hammond, M. L., Stearns, R. A., Evans, D. C., et al. (2002) · Chemical Research in Toxicology · doi:10.1021/tx0200109 · Cited by 154
Cytochromes P-450 in human hepatocyte plasma membrane: Recognition by several autoantibodies
Loeper, J., Descatoire, V., Maurice, M., Beaune, P. H., Belghiti, J., Houssin, D. P., Ballet, F., Feldmann, G., Guengerich, F. P., & Pessayre, D. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90853-5 · Cited by 153
Self-citation
Free radical–induced megamitochondria formation and apoptosis
Karbowski, M., Kurono, C., Woźniak, M., Ostrowski, M., Teranishi, M., Nishizawa, Y., Usukura, J., Soji, T., & Wakabayashi, T. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00209-3 · Cited by 153
Increased Production of Reactive Oxygen Species by Rat Liver Mitochondria After Chronic Ethanol Treatment
Kukielka, E., Dicker, E., & Cederbaum, A. I. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1127 · Cited by 153
Conversion of naphthalene to trans-naphthalene dihydrodiol: Evidence for the presence of a coupled aryl monooxygenase-epoxide hydrase system in hepatic microsomes
Oesch, F., & Daly, J. (1972) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(72)90807-8 · Cited by 153
Adverse reactions to sulphonamide and sulphonamide-trimethoprim antimicrobials: clinical syndromes and pathogenesis.
Cribb, A. E., Lee, B. L., Trepanier, L. A., & Spielberg, S. P. (1996) · PubMed · Cited by 153
Hepatic mitochondrial DNA deletion in alcoholics: Association with microvesicular steatosis
Fromenty, B., Grimbert, S., Mansouri, A., Beaugrand, M., Erlinger, S., Rötig, A., & Pessayre, D. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90024-1 · Cited by 151
Self-citation
Oxidation of alpha-methyldopa and other catechols by cytochrome P-450-generated superoxide anion: possible mechanism of methyldopa hepatitis.
Dybing, E., Nelson, S. D., Mitchell, J. R., Sasame, H. A., & Gillette, J. R. (1976) · PubMed · Cited by 149
In Vitro Metabolism of Tolcapone to Reactive Intermediates: Relevance to Tolcapone Liver Toxicity
Smith, K. S., Smith, P. L., Heady, T. N., Trugman, J. M., Harman, W. D., & Macdonald, T. L. (2003) · Chemical Research in Toxicology · doi:10.1021/tx025569n · Cited by 147
Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy #
Ingiliz, P., Valantin, M., Duvivier, C., Medja, F., Dominguez, S., Charlotte, F., Tubiana, R., Poynard, T., Katlama, C., Lombès, A., et al. (2008) · Hepatology · doi:10.1002/hep.22665 · Cited by 146
Pharmacogenetics of drug‐induced liver injury†
Russmann, S., Jetter, A., & Kullak-Ublick, G. A. (2010) · Hepatology · doi:10.1002/hep.23720 · Cited by 145
A prospective study of acute drug‐induced liver injury in patients suffering from non‐alcoholic fatty liver disease
Tarantino, G., Conca, P., Basile, V., Gentile, A., Capone, D., Polichetti, G., & Leo, E. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00072.x · Cited by 145
Inhibition of Isoprenoid Biosynthesis Induces Apoptosis in Human Promyelocytic HL-60 Cells
Pérez‐Sala, D., & Mollinedo, F. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1359 · Cited by 144
Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: Possible role in microvesicular steatosis induced by this antibiotic
Fréneaux, E., Labbe, G., Lettéron, P., Dinh, T. L., Degott, C., Genève, J., Larrey, D. G., & Pessayre, D. (1988) · Hepatology · doi:10.1002/hep.1840080513 · Cited by 144
Self-citation
Impaired adaptive resynthesis and prolonged depletion of hepatic mitochondrial DNA after repeated alcohol binges in mice
Demeilliers, C., Maisonneuve, C., Grodet, A., Mansouri, A., Nguyen, R. Q., Tinel, M., Lettéron, P., Degott, C., Feldmann, G., Pessayre, D., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.35952 · Cited by 144
Self-citation
Mitochondrial Involvement in Drug-Induced Liver Injury
Pessayre, D., Mansouri, A., Berson, A., & Fromenty, B. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00663-0_11 · Cited by 142
Self-citation
Tamoxifen Inhibits Topoisomerases, Depletes Mitochondrial DNA, and Triggers Steatosis in Mouse Liver
Larosche, I., Lettéron, P., Fromenty, B., Vadrot, N., Abbey‐Toby, A., Feldmann, G., Pessayre, D., & Mansouri, A. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.114546 · Cited by 142
Self-citation
Opening of the mitochondrial permeability transition pore causes matrix expansion and outer membrane rupture in fas-mediated hepatic apoptosis in mice
Feldmann, G., Haouzi, D., Moreau, A., Durand‐Schneider, A., Bringuier, A. F., Berson, A., Mansouri, A., Fau, D., & Pessayre, D. (2000) · Hepatology · doi:10.1002/hep.510310318 · Cited by 138
Self-citation
Isoniazid-rifampin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction.
Pessayre, D., Bentata, M., Degott, C., Nouel, O., Miguet, J., RUEFF, B., & Benhamou, J. (1977) · PubMed · Cited by 136
Self-citation
Immunological studies on the mechanism of halothane-induced hepatotoxicity: immunohistochemical evidence of trifluoroacetylated hepatocytes.
Satoh, H., Fukuda, Y., Anderson, D. K., Ferrans, V. J., Gillette, J. R., & Pohl, L. R. (1985) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22885-3 · Cited by 136
Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholic patients
Mansouri, A., Fromenty, B., Berson, A., Robin, M., Grimbert, S., Beaugrand, M., Erlinger, S., & Pessayre, D. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80286-3 · Cited by 136
Self-citation
Hepatitis C virus protein expression causes calcium-mediated mitochondrial bioenergetic dysfunction and nitro-oxidative stress
Piccoli, C., Scrima, R., Quarato, G., D’Aprile, A., Ripoli, M. C., Lecce, L., Boffoli, D., Moradpour, D., & Capitanio, N. (2007) · Hepatology · doi:10.1002/hep.21679 · Cited by 134
The metabolic syndrome in overweight epileptic patients treated with valproic acid
Verrotti, A., Manco, R., Agostinelli, S., Coppola, G., & Chiarelli, F. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02206.x · Cited by 134
Effect of fasting on metabolite-mediated hepatotoxicity in the rat
Pessayre, D., Dolder, A., Artigou, J., Wandscheer, J.-C., Descatoire, V., Degott, C., & Benhamou, J. (1979) · Gastroenterology · doi:10.1016/0016-5085(79)90275-0 · Cited by 133
Self-citation
Target identification of drug induced mitochondrial toxicity using immunocapture based OXPHOS activity assays
Nadanaciva, S., Bernal, A. J., Aggeler, R. J., Capaldi, R., & Will, Y. (2007) · Toxicology in Vitro · doi:10.1016/j.tiv.2007.01.011 · Cited by 133
The mitochondrial permeability transition: a new pathophysiological mechanism for Reye's syndrome and toxic liver injury.
Trost, L. C., & Lemasters, J. J. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20745-5 · Cited by 132
Effects of Aspirin and Acetaminophen on the Liver
Zimmerman, H. J. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340030065013 · Cited by 132
Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis
Robin, M., Roy, M. L., Descatoire, V., & Pessayre, D. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)82329-x · Cited by 129
Self-citation
Critical Role of c-Jun N-Terminal Protein Kinase Activation in Troglitazone-Induced Apoptosis of Human HepG2 Hepatoma Cells
Bae, M., & Song, B. J. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.2.401 · Cited by 129
Troglitazone Inhibits Fatty Acid Oxidation and Esterification, and Gluconeogenesis in Isolated Hepatocytes from Starved Rats
Fulgencio, J.-P., Kohl, C., Girard, J. R., & Pégorier, J. P. (1996) · Diabetes · doi:10.2337/diab.45.11.1556 · Cited by 129
Association of Noncirrhotic Portal Hypertension in HIV‐Infected Persons and Antiretroviral Therapy with Didanosine: A Nested Case‐Control Study
Kovari, H., Ledergerber, B., Peter, U., Flepp, M., Jost, J., Schmid, P., Calmy, A., Mueller, N. J., Muellhaupt, B., Weber, R. K., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/603559 · Cited by 128
Scavenging Peroxynitrite with Glutathione Promotes Regeneration and Enhances Survival during Acetaminophen-Induced Liver Injury in Mice
Bajt, M. L., Knight, T. R., Farhood, A. I., & Jaeschke, H. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052506 · Cited by 127
Amiodarone-Associated Phospholipidosis and Fibrosis of the Liver
Poucell, S., Ireton, J., Valencia‐Mayoral, P., Downar, E., Larratt, L. M., Patterson, J., Blendis, L. M., & Phillips, M. J. (1984) · Gastroenterology · doi:10.1016/s0016-5085(24)05145-x · Cited by 127
The metabolic activation of abacavir by human liver cytosol and expressed human alcohol dehydrogenase isozymes
Walsh, J. S. A., Reese, M. J., & Thurmond, L. M. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00059-5 · Cited by 125
Prediction of in Vivo Potential for Metabolic Activation of Drugs into Chemically Reactive Intermediate: Correlation of in Vitro and in Vivo Generation of Reactive Intermediates and in Vitro Glutathione Conjugate Formation in Rats and Humans
Masubuchi, N., Makino, C., & Murayama, N. (2007) · Chemical Research in Toxicology · doi:10.1021/tx060234h · Cited by 124
Combined glutathione-S -transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicity
Simon, T. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.104944 · Cited by 122
Acetylation Rates and Monthly Liver Function Tests during One Year of Isoniazid Preventive Therapy
Mitchell, J. R., Long, M. W., Thorgeirsson, U. P., & Jollow, D. J. (1975) · CHEST Journal · doi:10.1378/chest.68.2.181 · Cited by 122
Isoniazid-Rifampin Fulminant Hepatitis
Pessayre, D., Bentata, M., Degott, C., Nouel, O., Miguet, J., RUEFF, B., & Benhamou, J. (1977) · Gastroenterology · doi:10.1016/s0016-5085(77)80088-7 · Cited by 121
Self-citation
Deoxyribonucleotide Pool Imbalance Stimulates Deletions in HeLa Cell Mitochondrial DNA
Song, S., Wheeler, L. J., & Mathews, C. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300401200 · Cited by 120
Diterpenoids from germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes
Fau, D., Lekéhal, M., Farrell, G. C., Moreau, A., Moulis, C., Feldmann, G., Haouzi, D., & Pessayre, D. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9322529 · Cited by 120
Self-citation
Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid
Levy, R. H., Rettenmeier, A. W., Anderson, G. D., Wilensky, A. J., Friel, P. N., Baillie, T. A., Acheampong, A., Tor, J., Guyot, M., & Loiseau, P. (1990) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1990.144 · Cited by 119
Mechanism-Based Inactivation of Cytochrome P450 3A4 by Lapatinib
Teng, W.-C., Oh, J. W., New, L. S., Wahlin, M. D., Nelson, S. D., Ho, H. K., & Chan, E. C. Y. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.065839 · Cited by 119
Hepatotoxicity of germander in mice
Loeper, J., Descatoire, V., Lettéron, P., Moulis, C., Degott, C., Dansette, P. M., Fau, D., & Pessayre, D. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90606-8 · Cited by 118
Self-citation
Toxicity of Alpidem, a Peripheral Benzodiazepine Receptor Ligand, but Not Zolpidem, in Rat Hepatocytes: Role of Mitochondrial Permeability Transition and Metabolic Activation
Berson, A., Descatoire, V., Sutton, A., Fau, D., Maulny, B., Vadrot, N., Feldmann, G., BERTHON, B., Tordjmann, T., & Pessayre, D. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29292-2 · Cited by 118
Self-citation
Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) triggered by valproate therapy
Lam, C. W., Lau, C. H., Williams, J., Chan, Y., & Wong, L. J. (1997) · European Journal of Pediatrics · doi:10.1007/s004310050663 · Cited by 118
Lovastatin inhibits tumor growth and lung metastasis in mouse mammary carcinoma model: a p53-independent mitochondrial-mediated apoptotic mechanism
Shibata, M. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh201 · Cited by 118
Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease
Degoul, F., Sutton, A., Mansouri, A., Cepanec, C., Valla, D. C., Pessayre, D., Fromenty, B., Degott, C., & Beaugrand, M. (2001) · Gastroenterology · doi:10.1053/gast.2001.24051 · Cited by 117
Self-citation
Apoptosis and autophagy: Regulation of apoptosis by DNA damage signalling – roles of p53, p73 and HIPK2
Bitomsky, N., & Hofmann, T. G. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07331.x · Cited by 115
Mitochondrial Superoxide Dismutase and Glutathione Peroxidase in Idiosyncratic Drug-Induced Liver Injury
Lucena, M. I., García‐Martín, E., Andrade, R. J., Martínez, C., Stephens, C. M., Buitrago, J. D. R., Ulzurrun, E., Fernandez, C. M., Romero‐Gómez, M., Castiella, A., et al. (2010) · Hepatology · doi:10.1002/hep.23668 · Cited by 115
Mitochondrial diseases represent a risk factor for valproate‐induced fulminant liver failure
Krähenbühl, S., Brandner, S., Kleinle, S., Liechti, S., & Straumann, D. (2000) · Liver International · doi:10.1034/j.1600-0676.2000.020004346.x · Cited by 115
Fenofibrate Impairs Rat Mitochondrial Function by Inhibition of Respiratory Complex I
Brunmair, B., Lest, A., Staniek, K., Gras, F., Scharf, N., Roden, M., Nohl, H., Waldhäusl, W. K., & Fürnsinn, C. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068312 · Cited by 114
Enflurane Metabolism Produces Covalently Bound Liver Adducts Recognized by Antibodies from Patients with Halothane Hepatitis
Christ, D. D., Kenna, J. G., Hammerer, W., Satoh, H., & Pohl, L. R. (1988) · Anesthesiology · doi:10.1097/00000542-198812000-00006 · Cited by 113
Autoantibodies Associated with Volatile Anesthetic Hepatitis Found in the Sera of a Large Cohort of Pediatric Anesthesiologists
Njoku, D. B., Greenberg, R. S., Bourdi, M., Borkowf, C. B., Dake, E. M., Martin, J. L., & Pohl, L. R. (2002) · Anesthesia & Analgesia · doi:10.1097/00000539-200202000-00003 · Cited by 112
New Epidemiologic Evidence Confirming That Bias Does Not Explain the Aspirin/Reye's Syndrome Association
Forsyth, B. W. C. (1989) · JAMA · doi:10.1001/jama.1989.03420170061031 · Cited by 112
Betulinic acid induces cytochrome c release and apoptosis in a Bax/Bak-independent, permeability transition pore dependent fashion
Mullauer, F. B., Kessler, J. H., & Medema, J. P. (2008) · APOPTOSIS · doi:10.1007/s10495-008-0290-x · Cited by 112
Genotoxicity and carcinogenicity of metronidazole
Dobiáš, L., Černá, M., Rössner, P., & Šrám, R. J. (1994) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(94)90001-9 · Cited by 111
SREBP Activation by Antipsychotic- and Antidepressant-Drugs in Cultured Human Liver Cells: Relevance for Metabolic Side-Effects?
Raeder, M. B., Fernø, J., Vik‐Mo, A. O., & Steen, V. M. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9160-4 · Cited by 110
Troglitazone, but not rosiglitazone, damages mitochondrial DNA and induces mitochondrial dysfunction and cell death in human hepatocytes
Rachek, L. I., Yuzefovych, L. V., LeDoux, S. P., Julie, N. L., & Wilson, G. L. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.07.021 · Cited by 110
Microarray analysis in human hepatocytes suggests a mechanism for hepatotoxicity induced by trovafloxacin
Liguori, M. J., Anderson, M. G., Bukofzer, S., McKim, J. M., Pregenzer, J. F., Retief, J., Spear, B. B., & Waring, J. F. (2005) · Hepatology · doi:10.1002/hep.20514 · Cited by 110
Acetaminophen induces ER dependent signaling in mouse liver
Nagy, G., Kardon, T., Wunderlich, L., Szarka, A., Kiss, A., Schaff, Z., Bánhegyi, G., & Mandl, J. (2006) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2006.11.021 · Cited by 109
Involvement of the Dicarboxylate Carrier in the Protonophoric Action of Long-Chain Fatty Acids in Mitochondria
Wieckowski, M. R., & Wojtczak, L. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6298 · Cited by 108
Cytochrome P450-generated reactive metabolites cause mitochondrial permeability transition, caspase activation, and apoptosis in rat hepatocytes
Haouzi, D., Lekéhal, M., Moreau, A., Moulis, C., Feldmann, G., Robin, M., Lettéron, P., Fau, D., & Pessayre, D. (2000) · Hepatology · doi:10.1053/jhep.2000.9034 · Cited by 108
Self-citation
In vitro effects of valproate and valproate metabolites on mitochondrial oxidations
Ponchaut, S., HOOF, F. V., & Veitch, K. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90324-c · Cited by 107
Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver
Fernø, J., Vik‐Mo, A. O., Jassim, G., Håvik, B., Berge, K., Skrede, S., Gudbrandsen, O. A., Waage, J. E. R., Lunder, N., Mørk, S. J., et al. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1370-x · Cited by 107
Hepatitis C is a predictor of acute liver injury among hospitalizations for acetaminophen overdose in the United States: A nationwide analysis†
Nguyen, G. C., Sam, J., & Thuluvath, P. J. (2008) · Hepatology · doi:10.1002/hep.22536 · Cited by 107
Valproate therapy and nonalcoholic fatty liver disease
Luef, G. J., Waldmann, M., Sturm, W., Naser, A., Trinka, E., Unterberger, I., Bauer, G. J., & Lechleitner, M. (2004) · Annals of Neurology · doi:10.1002/ana.20074 · Cited by 107
Chloramphenicol toxicity: 25 years of research.
Yunis, A. A. (1989) · PubMed · Cited by 106
Degradation of Mcl-1 by Granzyme B
Han, J., Goldstein, L. A., Gastman, B., Froelich, C. J., Yin, X., & Rabinowich, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313234200 · Cited by 106
Localization of Multiple Forms of Inducible Cytochromes P450 in Rat Liver Mitochondria: Immunological Characteristics and Patterns of Xenobiotic Substrate Metabolism
Anandatheerthavarada, H. K., Addya, S., Dwivedi, R. S., Biswas, G., Mullick, J., & Avadhani, N. G. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.9855 · Cited by 106
N-Alkylprotoporphyrin IX formation in 3,5-dicarbethoxy-1,4-dihydrocollidine-treated rats. Transfer of the alkyl group from the substrate to the porphyrin.
de Montellano, P. R. O., Beilan, H. S., & Kunze, K. L. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)69049-6 · Cited by 105
Bioactivation of the Epidermal Growth Factor Receptor Inhibitor Gefitinib: Implications for Pulmonary and Hepatic Toxicities
Li, X., Kamenecka, T. M., & Cameron, M. D. (2009) · Chemical Research in Toxicology · doi:10.1021/tx900256y · Cited by 105
Glucocorticoids inhibit mitochondrial matrix acyl-CoA dehydrogenases and fatty acid beta-oxidation
Letteron, P., Brahimi-Bourouina, N., Robin, M. A., Moreau, A., Feldmann, G., & Pessayre, D. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.272.5.g1141 · Cited by 105
Self-citation
Identification and characterization of the glutathione and N-acetylcysteine conjugates of (E)-2-propyl-2,4-pentadienoic acid, a toxic metabolite of valproic acid, in rats and humans.
Kassahun, K., Farrell, K., & Abbott, F. S. (1991) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07155-7 · Cited by 105
Delayed cytotoxicity and cleavage of mitochondrial DNA in ciprofloxacin-treated mammalian cells.
Lawrence, J. W., Claire, D., Weissig, V., & Rowe, T. C. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09546-x · Cited by 104
The effects of valproate on intermediary metabolism in isolated rat hepatocytes and intact rats
Turnbull, D. M., Bone, A. J., Bartlett, K., Koundakjian, P. P., & Sherratt, H. S. A. (1983) · Biochemical Pharmacology · doi:10.1016/0006-2952(83)90054-0 · Cited by 103
Amiodarone-induced hepatic phospholipidosis: A morphological alteration independent of pseudoalcoholic liver disease
Guigui, B., Perrot, S., Berry, J. P., Fleury‐Feith, J., Martin, N., Métreau, J., Dhumeaux, D., & Zafrani, É. S. (1988) · Hepatology · doi:10.1002/hep.1840080514 · Cited by 103
Inhibition by perhexiline of oxidative phosphorylation and the β-oxidation of fatty acids: Possible role in pseudoalcoholic liver lesions
Deschamps, D., DeBeco, V., Fisch, C., Fromenty, B., Guillouzo, A., & Pessayre, D. (1994) · Hepatology · doi:10.1002/hep.1840190422 · Cited by 103
Self-citation
Effects of Modifying Structure on Electrophilic Reactions with Biological Nucleophiles
Coles, B. (1984) · Drug Metabolism Reviews · doi:10.3109/03602538409029962 · Cited by 102
Halothane Hepatitis
Farrell, G. C., Prendergast, D., & Murray, M. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511213132102 · Cited by 101
HIV protease inhibitors activate the unfolded protein response and disrupt lipid metabolism in primary hepatocytes
Zhou, H., Gurley, E. C., Brimson, S. J., Ding, H., Fang, Y., Xu, Z., Pandak, W. M., & Hylemon, P. B. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00182.2006 · Cited by 101
Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome.
Deschamps, D., Fisch, C., Fromenty, B., Berson, A., Degott, C., & Pessayre, D. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20562-6 · Cited by 101
Self-citation
Inhibition by perhexiline of oxidative phosphorylation and the beta-oxidation of fatty acids: possible role in pseudoalcoholic liver lesions.
Deschamps, D., DeBeco, V., Fisch, C., Fromenty, B., Guillouzo, A., & Pessayre, D. (1994) · PubMed · Cited by 100
Self-citation
Self-induction by triacetyloleandomycin of its own transformation into a metabolite forming a stable 456 nm-absorbing complex with cytochrome P-450
Pessayre, D., Descatoire, V., Konstantinova-Mitcheva, M., Wandscheer, J.-C., Cobert, B., Level, R., Benhamou, J., Jaouen, M., & Mansuy, D. (1981) · Biochemical Pharmacology · doi:10.1016/0006-2952(81)90125-8 · Cited by 100
Self-citation
Mechanisms of idiosyncratic drug reactions: the case of felbamate
Dieckhaus, C. M., Thompson, C. D., Roller, S. G., & Macdonald, T. L. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00057-1 · Cited by 100
Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors
Kubota, T., Fujisaki, K., Itoh, Y., Yano, T., Sendo, T., & Oishi, R. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.02.037 · Cited by 100
Mitochondrial permeability transition as a potential determinant of hepatotoxicity of antidiabetic thiazolidinediones
Masubuchi, Y., Kano, S., & Horie, T. (2006) · Toxicology · doi:10.1016/j.tox.2006.02.017 · Cited by 99
Underlying mitochondrial dysfunction triggers flutamide-induced oxidative liver injury in a mouse model of idiosyncratic drug toxicity
Kashimshetty, R., Desai, V. G., Kale, V. M., Lee, T., Moland, C. L., Branham, W. S., New, L. S., Chan, E. C. Y., Younis, H. S., & Boelsterli, U. A. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.05.007 · Cited by 99
Self-induction by erythromycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450.
Danan, G., Descatoire, V., & Pessayre, D. (1981) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32700-x · Cited by 98
Self-citation
Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings
Vispo, E., Moreno, A., Maida, I. R., Barreiro, P., Cuevas, A., Albertos, S., & Soriano, V. (2010) · AIDS · doi:10.1097/qad.0b013e3283389e26 · Cited by 98
Drug interactions and hepatitis produced by some macrolide antibiotics
Pessayre, D., Larrey, D. G., Funck‐Brentano, C., & Benhamou, J. P. (1985) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/16.suppl_a.181 · Cited by 98
Self-citation
Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation
Berson, A., Fau, D., Fornacciari, R., Degove-Goddard, P., Sutton, A., Descatoire, V., Haouzi, D., Lettéron, P., Moreau, A., Feldmann, G., et al. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00050-7 · Cited by 98
Self-citation
Tamoxifen-associated steatohepatitis - report of three cases
Cortez‐Pinto, H., Baptista, A., Camilo, M., Costa, E. B., Valente, A. I., & de Moura, M. C. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80316-5 · Cited by 97
Liver failure associated with mitochondrial DNA depletion
Morris, A. A. M., Taanman, J., Blake, J. C., Cooper, J. A. D., Lake, B. D., Malone, M., Love, S., Clayton, P. T., Leonard, J. V., & Schapira, A. H. V. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80278-x · Cited by 97
Metabolic Oxidative Cleavage of Thioesters: Evidence for the Formation of Sulfenic Acid Intermediates in the Bioactivation of the Antithrombotic Prodrugs Ticlopidine and Clopidogrel
Dansette, P. M., Libraire, J., Bertho, G., & Mansuy, D. (2009) · Chemical Research in Toxicology · doi:10.1021/tx8004828 · Cited by 97
Oxidation of Mitochondrial Proteins and DNA Following Administration of Ethanol
Wieland, P., & Lauterburg, B. H. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2202 · Cited by 96
Presence of Functional Cytochrome P–450 on Isolated Rat Hepatocyte Plasma Membrane
Loeper, J., Descatoire, V., Maurice, M., Beaune, P. H., Feldmann, G., Larrey, D. G., & Pessayre, D. (1990) · Hepatology · doi:10.1002/hep.1840110521 · Cited by 96
Self-citation
Dangerous liaisons: the role of “danger” signals in the immune response to gene therapy
Brown, B. D., & Lillicrap, D. (2002) · Blood · doi:10.1182/blood-2001-11-0067 · Cited by 96
Current concepts and new ideas on the mechanism of action of quinoline-containing antimalarials
Ginsburg, H., & Geary, T. G. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90038-4 · Cited by 95
Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis
Aires, C. C. P., IJlst, L., Stet, F. S., Prip‐Buus, C., de Almeida, I. T., Durán, M., Wanders, R. J. A., & Silva, M. F. B. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.10.011 · Cited by 95
Risk factors for methotrexate-induced abnormal laboratory monitoring results in patients with rheumatoid arthritis.
Kent, P. D., Luthra, H. S., & Michet, C. J. (2004) · PubMed · Cited by 94
Ethanol increases mitochondrial cytochrome P450 2E1 in mouse liver and rat hepatocytes
Robin, M., Sauvage, I., Grandperret, T., Descatoire, V., Pessayre, D., & Fromenty, B. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.11.029 · Cited by 94
Self-citation
Increased ethane exhalation, an in vivo index of lipid peroxidation, in alcohol-abusers.
Lettéron, P., Duchatelle, V., Berson, A., Fromenty, B., Fisch, C., Degott, C., Benhamou, J., & Pessayre, D. (1993) · Gut · doi:10.1136/gut.34.3.409 · Cited by 93
Self-citation
Accumulation of Mitochondrial DNA Mutations in Human Immunodeficiency Virus–Infected Patients Treated with Nucleoside-Analogue Reverse-Transcriptase Inhibitors
Martin, A. M., Hammond, E., Nolan, D. A., Pace, C. S., den Boer, M. A. M., Taylor, L., Moore, H. C., Martinez, O. P., Christiansen, F., & Mallal, S. A. (2003) · The American Journal of Human Genetics · doi:10.1086/367849 · Cited by 93
Hydroxylated metabolites of the antimalarial drug primaquine. Oxidation and redox cycling.
Vasquez-Vivar, J. M., & Augusto, O. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50504-x · Cited by 92
Amodiaquine-lnduced Hepatitis
Larrey, D. G., CASTOT, A., Pessayre, D., MERIGOT, P., MACHAYEKHY, J.-P., FELDMANN, G., LENOIR, A., RUEFF, B., & BENHAMOU, J.-P. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-104-6-801 · Cited by 92
Self-citation
Hepatotoxicity of 3,4-methylenedioxyamphetamine and ?-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates
Bastos, M. D. L., Carvalho, M. X. E. R., Milhazes, N., Remião, F., Borges, F., Fernandes, E. G. R., Amado, F. M. L., Monks, T. J., & Carvalho, F. D. (2004) · Archives of Toxicology · doi:10.1007/s00204-003-0510-7 · Cited by 92
Paracetamol‐induced hepatotoxicity at recommended dosage
Kurtovic, J., & Riordan, S. M. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01097.x · Cited by 92
Drugs interfering with mitochondrial disorders
Finsterer, J., & Segall, L. (2009) · Drug and Chemical Toxicology · doi:10.3109/01480540903207076 · Cited by 92
Hepatitis after intravenous buprenorphine misuse in heroin addicts
Berson, A., Gervais, A., Cazals-Hatem, D. L., Boyer, N., Durand, F., Bernuau, J., Marcellin, P., Degott, C., Valla, D. C., & Pessayre, D. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00049-0 · Cited by 92
Self-citation
Interferon selectively inhibits the expression of mitochondrial genes: a novel pathway for interferon‐mediated responses.
Shan, B., Vazquez, E., & Lewis, J. A. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07879.x · Cited by 91
Human Microsomal Epoxide Hydrolase Is the Target of Germander-Induced Autoantibodies on the Surface of Human Hepatocytes
de Berardinis, V., Moulis, C., Maurice, M., Beaune, P. H., Pessayre, D., Pompon, D., & Loeper, J. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.3.542 · Cited by 91
Self-citation
Stereoselective and nonstereoselective effects of ibuprofen enantiomers on mitochondrial beta-oxidation of fatty acids.
Fréneaux, E., Fromenty, B., Berson, A., Labbe, G., Degott, C., Lettéron, P., Larrey, D. G., & Pessayre, D. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22933-0 · Cited by 91
Self-citation
Bioactivation of diclofenac via benzoquinone imine intermediates-identification of urinary mercapturic acid derivatives in rats and humans.
Poon, G. K., Chen, Q., Teffera, Y., Ngui, J. S., Griffin, P. R., Braun, M. P., Doss, G. A., Freeden, C., Stearns, R. A., Evans, D. C., et al. (2001) · PubMed · Cited by 91
Metabolic Activation of Nevirapine in Human Liver Microsomes: Dehydrogenation and Inactivation of Cytochrome P450 3A4
Wen, B., Chen, Y., & Fitch, W. L. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.024851 · Cited by 90
Interactions of dihydralazine with cytochromes P4501A: a possible explanation for the appearance of anti-cytochrome P4501A2 autoantibodies.
Bourdi, M., Tinel, M., Beaune, P. H., & Pessayre, D. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10602-0 · Cited by 90
Self-citation
Human‐liver cytochromes P‐450 expressed in yeast as tools for reactive‐metabolite formation studies
Garcia, M., Dansette, P. M., Valadon, P., Amar, C., Beaune, P. H., Guengerich, F. P., & Mansuy, D. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17752.x · Cited by 89
The hepatic mitochondrial DNA depletion syndrome: Ultrastructural changes in liver biopsies
Mandel, H., Hartman, C., Berkowitz, D., Elpeleg, O., Manov, I., & Iancu, T. C. (2001) · Hepatology · doi:10.1053/jhep.2001.27664 · Cited by 89
Molecular characterization of inherited medium-chain acyl-CoA dehydrogenase deficiency.
Kelly, D. P., Whelan, A. J., Ogden, M. L., Alpers, R., Zhang, Z. F., Bellus, G. A., Gregersen, N. V., DORLAND, L., & Strauss, A. W. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.23.9236 · Cited by 88
Zidovudine (Azt) Causes An Oxidation of Mitochondrial Dna in Mouse Liver
de la Asunción, J. G., del Olmo, M. L., Sastre, J., Pallardó, F. V., & Viña, J. (1999) · Hepatology · doi:10.1002/hep.510290353 · Cited by 88
Novel Mutation of Human DNA Polymerase γ Associated with Mitochondrial Toxicity Induced by Anti‐HIV Treatment
Yamanaka, H., Gatanaga, H., Kosalaraksa, P., Matsuoka, S., Takahashi, T., Kimura, S., & Oka, S. (2007) · The Journal of Infectious Diseases · doi:10.1086/513872 · Cited by 87
Mechanisms of Inhibition and Uncoupling of Respiration in Isolated Rat Liver Mitochondria by the General Anesthetic 2,6‐Diisopropylphenol
Kigoulet, M., Devin, A., Avéret, N., Vandais, B., & Guérin, B. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0280t.x · Cited by 87
3′-Azido-3′-deoxythymidine uptake into isolated rat liver mitochondria and impairment of ADP/ATP translocator
Barile, M., Valenti, D., Passarella, S., & Quagliariello, E. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00831-3 · Cited by 87
Mechanism of metabolic activation of chloroform by rat liver microsomes
Pohl, L. R., Martin, J. L., & George, J. W. (1980) · Biochemical Pharmacology · doi:10.1016/0006-2952(80)90302-0 · Cited by 87
Alterations of Cell Volume Regulation in the Development of Hepatocyte Necrosis
Carini, R., Autelli, R., Bellomo, G., & Albano, E. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4408 · Cited by 87
Autoantibodies against Cytochromes P450: Role in Human Diseases
Beaune, P. H., Pessayre, D., Dansette, P. M., Mansuy, D., & Manns, M. P. (1994) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60175-1 · Cited by 86
Self-citation
Chloroquine-induced phospholipid fatty liver. Measurement of drug and lipid concentrations in rat liver lysosomes.
Hostetler, K. Y., Reasor, M. J., & Yazaki, P. J. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89718-6 · Cited by 86
Interactions of Macrolide Antibiotics (Erythromycin A, Roxithromycin, Erythromycylamine [Dirithromycin], and Azithromycin) with Phospholipids: Computer-Aided Conformational Analysis and Studies on Acellular and Cell Culture Models
Montenez, J. P., Françoise Van Bambeke, A., Piret, J., Brasseur, R., Tulkens, P. M., & Mingeot-Leclercq, M. P. (1999) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8632 · Cited by 86
Role of hepatic metabolism in the bioactivation and detoxication of amodiaquine
Jewell, H., Maggs, J. L., Harrison, A. C., O’Neill, P. M., Ruscoe, J. E., & Park, B. K. (1995) · Xenobiotica · doi:10.3109/00498259509061845 · Cited by 86
Role of reactive metabolites in drug-induced hepatitis
Pessayre, D. (1995) · Journal of Hepatology · doi:10.1016/s0168-8278(21)80002-1 · Cited by 86
Self-citation
Reversible tenfod reduction in mitochondrial DNA content of human cells treated with ethidium bromide
Wiseman, A., & Attardi, G. M. (1978) · Molecular and General Genetics MGG · doi:10.1007/bf00270321 · Cited by 85
Inhibition of medium-chain fatty acid β-oxidationinvitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acid
Bjorge, S. M., & Baillie, T. A. (1985) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(85)91014-9 · Cited by 85
Inhibition of mitochondrial protein synthesis promotes increased stability of nuclear-encoded respiratory gene transcripts.
Chrzanowska‐Lightowlers, Z. M., Preiß, T., & Lightowlers, R. N. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)46988-8 · Cited by 85
Metabolic activation of nitrofurantoin—possible implications for carcinogenesis
Boyd, M. R., Stiko, A., & Sasame, H. A. (1979) · Biochemical Pharmacology · doi:10.1016/0006-2952(79)90142-4 · Cited by 85
Genetically determined polymorphisms in drug oxidation
Jacqz, E., Hall, S. D., & Branch, R. A. (1986) · Hepatology · doi:10.1002/hep.1840060534 · Cited by 85
The Role of Tumor Necrosis Factor Alpha in Lipopolysaccharide/Ranitidine-Induced Inflammatory Liver Injury
Tukov, F. F., Luyendyk, J. P., Ganey, P. E., & Roth, R. A. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm209 · Cited by 85
Studies on the biotransformation in the perfused rat liver of 2-n-propyl-4-pentenoic acid, a metabolite of the antiepileptic drug valproic acid. Evidence for the formation of chemically reactive intermediates.
Rettenmeier, A. W., Prickett, K. S., Gordon, W. P., Bjorge, S. M., Chang, S. L., Lévy, R. H., & Baillie, T. A. (1985) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07823-7 · Cited by 85
Hydrogen peroxide overproduction in megamitochondria of troglitazone-treated human hepatocytes
Shishido, S., Koga, H., Harada, M., Kumemura, H., Hanada, S., Taniguchi, E., Kumashiro, R., Ohira, H., Satô, Y., Namba, M., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50014 · Cited by 83
Effects of clarithromycin on cytochrome P-450. Comparison with other macrolides.
Tinel, M., Descatoire, V., Larrey, D. G., Loeper, J., Labbe, G., Lettéron, P., & Pessayre, D. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22274-1 · Cited by 82
Self-citation
Metabolic activation of furosemide to a chemically reactive, hepatotoxic metabolite.
Mitchell, J. R., Nelson, W. L., Potter, W. Z., Sasame, H. A., & Jollow, D. J. (1976) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30654-3 · Cited by 82
Liver Injury in Acute Fatty Liver of Pregnancy: Possible Link to Placental Mitochondrial Dysfunction and Oxidative Stress
Natarajan, S. K., Thangaraj, K. R., Eapen, C. E., Ramachandran, A., Mukhopadhya, A., Mathai, M., Seshadri, L., Peedikayil, A. V., Ramakrishna, B., & Balasubramanian, K. A. (2009) · Hepatology · doi:10.1002/hep.23245 · Cited by 80
Immune mechanisms in tienilic acid associated hepatotoxicity.
Neuberger, J., & Williams, R. L. (1989) · Gut · doi:10.1136/gut.30.4.515 · Cited by 80
Valproate-Induced Insulin Resistance and Obesity in Children
Verrotti, A., la Torre, R., Trotta, D., Mohn, A., & Chiarelli, F. (2009) · Hormone Research in Paediatrics · doi:10.1159/000197868 · Cited by 80
Possible role of HLA in hepatotoxicity
Berson, A., Fréneaux, E., Larrey, D. G., Lepage, V., Douay, C., Mallet, C., Fromenty, B., Benhamou, J., & Pessayre, D. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80004-9 · Cited by 79
Self-citation
Cytochrome P450-Mediated Bioactivation of the Epidermal Growth Factor Receptor Inhibitor Erlotinib to a Reactive Electrophile
Li, X., Kamenecka, T. M., & Cameron, M. D. (2010) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.030361 · Cited by 79
Hepatic Mitochondrial DNA Depletion after an Alcohol Binge in Mice: Probable Role of Peroxynitrite and Modulation by Manganese Superoxide Dismutase
Larosche, I., Lettéron, P., Berson, A., Fromenty, B., Huang, T., Moreau, R., Pessayre, D., & Mansouri, A. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.160879 · Cited by 79
Self-citation
4‐Quinolones cause a selective loss of mitochondrial DNA from mouse L1210 leukemia cells
Lawrence, J. W., Darkin‐Rattray, S. J., Xie, F., Neims, A. H., & Rowe, T. C. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240510208 · Cited by 78
Synergistic Movements of Ca2+ and Bax in Cells Undergoing Apoptosis
Pan, Z., Bhat, M. B., Nieminen, A., & Ma, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100178200 · Cited by 78
The 2–5A/RNase L/RNase L Inhibitor (RNI) Pathway Regulates Mitochondrial mRNAs Stability in Interferon α-treated H9 Cells
Roy, F. L., Bisbal, C., Silhol, M., Martinand‐Mari, C., Lebleu, B., & Salehzada, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107482200 · Cited by 77
Impaired mitochondrial beta-oxidation in a patient with an abnormality of the respiratory chain. Studies in skeletal muscle mitochondria.
Watmough, N. J., Bindoff, L. A., Birch‐Machin, M. A., Jackson, S., Bartlett, K., RAGAN, C. I., Poulton, J., Gardiner, R. M., Sherratt, H. S. A., & Turnbull, D. M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114409 · Cited by 77
Absence of a Universal Mechanism of Mitochondrial Toxicity by Nucleoside Analogs
Lund, K. C., Peterson, L., & Wallace, K. B. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00039-07 · Cited by 77
Sequential Metabolism and Bioactivation of the Hepatotoxin Benzbromarone: Formation of Glutathione Adducts From a Catechol Intermediate
McDonald, M. G., & Rettie, A. E. (2007) · Chemical Research in Toxicology · doi:10.1021/tx7001228 · Cited by 77
Inhibition of mitochondrial beta-oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti-inflammatory drug.
Genève, J., Hayat-Bonan, B., Labbe, G., Degott, C., Lettéron, P., Fréneaux, E., Dinh, T. L., Larrey, D. G., & Pessayre, D. (1987) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39166-4 · Cited by 77
Self-citation
Hépatotoxicité des médicaments 14e mise à jour du fichier bibliographique des atteintes hépatiques et des médicaments responsables
Biour, M., Salem, C. B., Chazouillères, O., Grangé, J., Serfati, L., & Poupon, R. Y. (2004) · Gastroentérologie Clinique et Biologique · doi:10.1016/s0399-8320(04)95062-2 · Cited by 76
Antigenic targets in tienilic acid hepatitis. Both cytochrome P450 2C11 and 2C11-tienilic acid adducts are transported to the plasma membrane of rat hepatocytes and recognized by human sera.
Robin, M. A., Maratrat, M., Roy, M. L., Breton, F. P. L., Bonierbale, E., Dansette, P. M., Ballet, F., Mansuy, D., & Pessayre, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118936 · Cited by 76
Self-citation
Keratin Variants Predispose to Acute Liver Failure and Adverse Outcome: Race and Ethnic Associations
Strnad, P., Zhou, Q., Hanada, S., Lazzeroni, L. C., Zhong, B., So, P., Davern, T. J., Lee, W. M., & Omary, M. B. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.007 · Cited by 76
Macrophage activation by factors released from acetaminophen-injured hepatocytes: Potential role of HMGB1
Dragomir, A.-C., Laskin, J. D., & Laskin, D. L. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.04.003 · Cited by 76
Potential metabolic basis for enflurane hepatitis and the apparent cross-sensitization between enflurane and halothane.
Christ, D. D., Satoh, H., Kenna, J. G., & Pohl, L. R. (1988) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06888-6 · Cited by 76
Alteration of Na+ homeostasis as a critical step in the development of irreversible hepatocyte injury after adenosine triphosphate depletion
Carini, R., Bellomo, G., Benedetti, A., Fulceri, R., Gamberucci, A., Parola, M., Dianzani, M. U., & Albano, E. (1995) · Hepatology · doi:10.1002/hep.1840210431 · Cited by 75
Decreased mitochondrial oxidation of fatty acids in pregnant mice: Possible relevance to development of acute fatty liver of pregnancy
Grimbert, S., Fromenty, B., Fisch, C., Lettéron, P., Berson, A., Durand-Schneider, A. M., Feldmann, G., & Pessayre, D. (1993) · Hepatology · doi:10.1002/hep.1840170417 · Cited by 75
Self-citation
Metabolic activation of unsaturated derivatives of valproic acid. Identification of novel glutathione adducts formed through coenzyme A-dependent and -independent processes
Kassahun, K., Hu, P. L., Grillo, M. P., Davis, M. R., Jin, L., & Baillie, T. A. (1994) · Chemico-Biological Interactions · doi:10.1016/0009-2797(94)90014-0 · Cited by 74
Inactivation of human liver cytochrome P-450 by the drug methoxsalen and other psoralen derivatives
Tinel, M., Belghiti, J., Descatoire, V., Amouyal, G., Lettéron, P., Genève, J., Larrey, D. G., & Pessayre, D. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90190-0 · Cited by 74
Self-citation
Uncoupling of rat and human mitochondria: A possible explanation for tacrine-induced liver dysfunction
Berson, A., Renault, S., Lettéron, P., Robin, M., Fromenty, B., Fau, D., Bot, M. A. L., Riché, C., Durand‐Schneider, A., Feldmann, G., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8964414 · Cited by 74
Self-citation
Tacrine Inhibits Topoisomerases and Dna Synthesis to Cause Mitochondrial Dna Depletion and Apoptosis in Mouse Liver
Mansouri, A., Haouzi, D., Descatoire, V., Demeilliers, C., Sutton, A., Vadrot, N., Fromenty, B., Feldmann, G., Pessayre, D., & Berson, A. (2003) · Hepatology · doi:10.1053/jhep.2003.50353 · Cited by 74
Self-citation
Mitochondrial CYP2E1 is sufficient to mediate oxidative stress and cytotoxicity induced by ethanol and acetaminophen
Knockaert, L., Descatoire, V., Vadrot, N., Fromenty, B., & Robin, M. (2010) · Toxicology in Vitro · doi:10.1016/j.tiv.2010.11.019 · Cited by 74
Self-citation
Genetic Polymorphisms in Antioxidant Enzymes Modulate Hepatic Iron Accumulation and Hepatocellular Carcinoma Development in Patients with Alcohol-Induced Cirrhosis
Sutton, A., Nahon, P., Pessayre, D., Rufat, P., Poiré, A., Ziol, M., Vidaud, D., Barget, N., Ganne‐Carrié, N., Charnaux, N., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2566 · Cited by 74
Self-citation
Caspase- and mitochondrial dysfunction-dependent mechanisms of lysosomal leakage and cathepsin B activation in DNA damage-induced apoptosis
Paquet, C., Sané, A.-T., Beauchemin, M., & Bertrand, R. (2005) · Leukemia · doi:10.1038/sj.leu.2403717 · Cited by 73
Metabolic activation of trichloroethylene into a chemically reactive metabolite toxic to the liver.
Allemand, H., Pessayre, D., Descatoire, V., Degott, C., Feldmann, G., & Benhamou, J. P. (1978) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31189-4 · Cited by 73
Self-citation
Fatal neonatal liver failure and mitochondrial cytopathy (oxidative phosphorylation deficiency): A light and electron microscopic study of the liver
Bioulac‐Sage, P., Parrot-Roulaud, F., Mazat, J. P., Lamireau, T., Coquet, M., Sandler, B., Demarquez, J. L., Cormier‐Daire, V., Münnich, A., Carré, M., et al. (1993) · Hepatology · doi:10.1002/hep.1840180414 · Cited by 73
Mitochondrial respiratory chain disorders and the liver
Morris, A. A. M. (1999) · Liver International · doi:10.1111/j.1478-3231.1999.tb00063.x · Cited by 72
Antipsychotic drug action on SREBPs-related lipogenesis and cholesterogenesis in primary rat hepatocytes
Lauressergues, E., Staels, B., Valeille, K., Majd, Z., Hum, D. W., Duriez, P., & Cussac, D. (2010) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-010-0499-4 · Cited by 72
Chloroquine-Mediated Radiosensitization is due to the Destabilization of the Lysosomal Membrane and Subsequent Induction of Cell Death by Necrosis
Zhao, H. W., Cai, Y., Santi, S. A., Lafrenie, R. M., & Lee, H. (2005) · Radiation Research · doi:10.1667/rr3436.1 · Cited by 71
N-acetyl-p-benzoquinone imine induces Ca2+ release from mitochondria by stimulating pyridine nucleotide hydrolysis.
Weis, M., Kass, G. E. N., Orrenius, S., & Moldéus, P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48355-x · Cited by 69
Two Types of Binding of Erythromycin to Ribosomes from Antibiotic-sensitive and -resistant Bacillus subtilis 168
Oleinick, N. L., & Corcoran, J. W. (1969) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94413-3 · Cited by 68
The Effect of Ethanol on the β‐Oxidation of Fatty Acids
Grunnet, N., & Kondrup, J. (1986) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1986.tb05182.x · Cited by 68
Severe Drug-induced Liver Injury Associated with Prolonged Use of Linezolid
Bus, L. D., Depuydt, P. O., Libbrecht, L. J., Vandekerckhove, L., Nollet, J., Benoît, D., Vogelaers, D., & Vlierberghe, H. V. (2010) · Journal of Medical Toxicology · doi:10.1007/s13181-010-0047-0 · Cited by 68
Halothane Biotransformation in Obese and Nonobese Patients
Bentley, J. B., Vaughan, R. W., Gandolfi, A. J., & Cork, R. C. (1982) · Anesthesiology · doi:10.1097/00000542-198208000-00005 · Cited by 67
Inhibition of Mitochondrial Function by Interferon
Lewis, J. A., Huq, A., & Najarro, P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.13184 · Cited by 67
Nonalcoholic fatty liver with alcoholic hyalin after long-term glucocorticoid therapy.
Itoh, S., Igarashi, M., Tsukada, Y., & Ichinoe, A. (1977) · PubMed · Cited by 66
Decreasing Trends in Reye Syndrome and Aspirin Use in Michigan, 1979 to 1984
Remington, P., Rowley, D. L., McGee, H., Hall, W. N., & Monto, A. S. (1986) · PEDIATRICS · doi:10.1542/peds.77.1.93 · Cited by 66
Drug Antigenicity, Immunogenicity, and Costimulatory Signaling: Evidence for Formation of a Functional Antigen through Immune Cell Metabolism
Elsheikh, A., Lavergne, S. N., Castrejón-Flores, J. L., Farrell, J., Wang, H., Sathish, J. G., Pichler, W. J., Park, B. K., & Naisbitt, D. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000889 · Cited by 66
Comparison of the biotransformation and hepatotoxicity of halothane and deuterated halothane.
Sipes, I. G., Gandolfi, A. J., Pohl, L. R., Krishna, G., & Brown, B. R. (1980) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32240-8 · Cited by 66
Evidence for a Medium-Chain Fatty Acid: Coenzyme A Ligase (Adenosine Monophosphate) That Activates Salicylate
Killenberg, P. G., Davidson, E. D., & Webster, L. T. (1971) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12727-2 · Cited by 66
Halothane-Related Hepatitis
MOULT, P. J. A., & Sherlock, S. (1975) · QJM · doi:10.1093/oxfordjournals.qjmed.a067419 · Cited by 66
Tianeptine, a new tricyclic antidepressant metabolized by β-oxidation of its heptanoic side chain, inhibits the mitochondrial oxidation of medium and short chain fatty acids in mice
Fromenty, B., Fréneaux, E., Labbe, G., Deschamps, D., Larrey, D. G., Lettéron, P., & Pessayre, D. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90580-7 · Cited by 65
Self-citation
Effect of Antipsychotic Medications on Glucose and Lipid Levels
Chaggar, P. S., Shaw, S. M., & Williams, S. G. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010368678 · Cited by 65
Metabolic activation of the nitroaromatic antiandrogen flutamide by rat and human cytochromes P-450, including forms belonging to the 3A and 1A subfamilies.
Berson, A., Wolf, C., Chachaty, C., Fisch, C., Fau, D., Eugene, D., Loeper, J., Gauthier, J.-C., Beaune, P. H., & Pompon, D. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38106-1 · Cited by 65
Self-citation
Additive effects of inducers and fasting on acetaminophen hepatotoxicity
Pessayre, D., Wandscheer, J.-C., Cobert, B., Level, R., Degott, C., Batt, A. M., Martin, N., & Benhamou, J. (1980) · Biochemical Pharmacology · doi:10.1016/0006-2952(80)90201-4 · Cited by 64
Self-citation
Coexposure of Mice to Trovafloxacin and Lipopolysaccharide, a Model of Idiosyncratic Hepatotoxicity, Results in a Unique Gene Expression Profile and Interferon Gamma–Dependent Liver Injury
Shaw, P. J., Ditewig, A. C., Waring, J. F., Liguori, M. J., Blomme, E. A. G., Ganey, P. E., & Roth, R. A. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn205 · Cited by 64

Flagged first, then by citations

Research works printed but not linked: 33

Albrecht H., 1995, J Inflamm, 45, 64
Bedossa P., 1994, Hepatology, 19, 1262
Brivet F. G., 1999, J Hepatol, 30, 364
Carini R., 1995, Hepatology, 21, 1089
Chabrol B., 1994, Eur J Pediatr, 153, 133
Clarke L., 1989, Cancer Res, 49, 2344
Cribb A. E., 1996, Adverse Drug React Toxicol Rev, 15, 9
Curzio M., 1985, Int J Tissue React, 7, 137
De la Iglesia F. A., 1974, Lab Invest, 4, 539
Dutertre J. P., 1991, Eur J Gastroenterol Hepatol, 3, 953
Dybing E., 1976, Mol Pharmacol, 12, 911
Feigelson H. S., 1997, Cancer Res, 57, 1063
Feigelson H. S., 1998, Cancer Res, 58, 585
Grimbert S., 1995, Am J Physiol, 268, G107
Itoh S., 1977, Acta Hepato-Gastroenterol, 24, 415
Kent P. D., 2004, J Rheumatol, 31, 1727
Lettéron P., 1997, Am J Physiol, 272, G1141
Lillibridge J. H., 1997, Drug Metab Dispos, 24, 509
Lucena MI, 2011, Gastroenterology
Moult P. J., 1975, Q J Med, 44, 99
Nass M. M., 1984, Cancer Res, 44, 2677
Ohnishi T., 2005, Oncol Rep, 13, 485
Pessayre D., 1980, Biochem Pharmacol, 29, 219
Poon G. K., 2001, Drug Metab Dispos, 29, 1608
10.1001/jama.1988.03410210079041 · DOI
Roy S., 1980, Res Commun Chem Pathol Pharmacol, 27, 507
Susin S A., 1998, Biochim Biophys Acta, 15, 1
10.1097/00008571-200303000-00004 · DOI
Wang M., 1998, Drug Metab Dispos, 26, 98
Wen B., 2011, Drug Metab Dispos
Werner S., 1996, Cancer Res, 56, 4391
Yunis A. A., 1989, Am J Med, 87, N44
Zhang Z., 1993, Am J Hum Genet, 52, 1111

Sorted by citations

Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases
Mansouri, A., Gattolliat, C., & Asselah, T. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.06.083 · Cited by 839
Self-citation
Molecular pathways of nonalcoholic fatty liver disease development and progression
Bessone, F., Razori, M. V., & Roma, M. G. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2947-0 · Cited by 664
The past and present of serum aminotransferases and the future of liver injury biomarkers
McGill, M. R. (2016) · EXCLI journal · doi:10.17179/excli2016-800 · Cited by 488
Mitochondrial alterations in fatty liver diseases
Fromenty, B., & Roden, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.09.020 · Cited by 448
Self-citation
Drug-induced liver injury: Interactions between drug properties and host factors
Chen, M., Suzuki, A., Borlak, J. T., Andrade, R. J., & Lucena, M. I. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.016 · Cited by 410

See all 277

Authors: Pessayre, D., Fromenty, B., Berson, A., Robin, M.-A., Lettéron, P., Moreau, R., & Mansouri, A.
Affiliations: Inserm (FR)
Corresponding author: Pessayre, Dominique
ORCID: Fromenty, Bernard
Moreau, Richard
Mansouri, Abdellah
Venue: Drug Metabolism Reviews
Publisher: Informa UK Limited
Published: 2012-01-30
Volume: 44
Issue: 1
Pages: 34-87
ISSN: 0360-2532 (ISSN-L)
1097-9883
DOI: 10.3109/03602532.2011.604086
OpenAlex: W2076781542
Cited by: 277
References: 604
Citations by year: 2026: 13 · 2025: 17 · 2024: 11 · 2023: 21 · 2022: 22 · 2021: 31 · 2020: 16 · 2019: 15 · 2018: 26 · 2017: 19 · 2016: 21 · 2015: 26 · 2014: 23 · 2013: 13 · 2012: 2
FWCI: 1.75
Type: journal article
Language: en
Open access: closed
Locations: Drug Metabolism Reviews (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords: drug-induced liver injury, mitochondrial dysfunction, reactive drug metabolites, mitochondrial membrane disruption, oxidative phosphorylation, ATP synthase inhibition, mitochondrial DNA damage, lactic acidosis, hepatic steatosis, steatosis, lipid peroxidation, human leukocyte antigen, genetic susceptibility, drug safety testing
MeSH terms: DNA, Mitochondrial, Pharmaceutical Preparations, Fatty Liver, Humans, Immune System, Liver, Mitochondria, Liver, Oxidation-Reduction, Reactive Oxygen Species, Cell Respiration, Mitochondrial Proteins, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Central role of mitochondria in drug-induced liver injury

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks